Latest Lead News

Elevra Lithium has completed a transformative merger and maintained robust production at its North American Lithium operation, while unveiling a compelling expansion plan that could boost output by 55% and slash costs.

Industrial Minerals Ltd has announced a maiden inferred mineral resource of 6.2 million tonnes at 98% silica for its Pippingarra Quarry Project in Western Australia, positioning the company to meet growing global demand for high purity quartz.

VRX Silica Limited has secured critical environmental and mining approvals for its Arrowsmith North silica sand project, alongside binding offtake contracts with major Asian customers, setting the stage for production by late 2026.

Rubix Resources has completed co-funded drilling at its Paperbark Project in Queensland and is progressing due diligence on a potential new asset, with assay results expected soon.

An application to the Takeovers Panel questions the integrity of Maronan Metals’ recent $16 million placement and its share purchase plan, raising concerns about undisclosed relationships and share price manipulation.

Godolphin Resources has reported a substantial upgrade to its Lewis Ponds gold, silver, and base metals resource, alongside successful capital raising to fund ongoing development and exploration.

Austal Limited reported a robust FY2025 with revenue up 24% and EBIT doubling, underpinned by a landmark Strategic Shipbuilding Agreement with the Australian Government and significant US contract wins.

Arafura Rare Earths has made decisive strides in funding its Nolans Project, securing up to US$400 million in conditional and indicative investments from Australian and US government-linked financiers, alongside a strong equity raise.

Metgasco Ltd (ASX, MEL) has announced a significant security consolidation, converting every 50 existing securities into one new security, impacting shares and options alike. Key dates and approval processes are set for late 2025.

Trek Metals has completed a major Phase 2 drilling campaign at its Christmas Creek Gold Project, revealing visible gold in diamond cores and extending high-grade gold zones. The company also advances its manganese project divestment amid a $2.05 million cash position.

Anteris Technologies Global Corp. has raised A$38.5 million in a private placement to accelerate the global commercialization and pivotal clinical trial of its innovative DurAVR® transcatheter aortic valve replacement device.

Neurotech International has initiated an Authorised Prescriber program for its lead therapy NTI164, expanding access for children with neurodevelopmental disorders in Australia. The company also secured a Rare Pediatric Disease Designation from the US FDA for NTI164 in Rett Syndrome, marking a key regulatory milestone.